Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe neutropenia: a diagnostic approach.

Literature DB >> 10778379

Severe neutropenia: a diagnostic approach.

H G Munshi¹, R B Montgomery.

Abstract

Entities: Disease

Mesh：

Year: 2000 PMID： 10778379 PMCID： PMC1070837 DOI： 10.1136/ewjm.172.4.248

Source DB: PubMed Journal: West J Med ISSN： 0093-0415

× No keyword cloud information.

29 in total

Review 1. Autoimmune neutropenia.

Authors: J Bux; C Mueller-Eckhardt
Journal: Semin Hematol Date: 1992-01 Impact factor: 3.851

Review 2. Differential diagnoses of bone marrow granuloma.

Authors: A Eid; W Carion; J S Nystrom
Journal: West J Med Date: 1996-06

Review 3. Immunology of sarcoidosis.

Authors: Y P Kataria; J F Holter
Journal: Clin Chest Med Date: 1997-12 Impact factor: 2.878

4. 1997 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

Authors:
Journal: J Clin Oncol Date: 1997-10 Impact factor: 44.544

5. Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis.

Authors: D F Stroncek; G M Vercellotti; D E Hammerschmidt; D J Christie; R A Shankar; H S Jacob
Journal: Blood Date: 1992-07-01 Impact factor: 22.113

6. Descriptive epidemiology of agranulocytosis.

Authors: B L Strom; J L Carson; R Schinnar; E S Snyder; M Shaw
Journal: Arch Intern Med Date: 1992-07

Review 7. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.

Authors:
Journal: J Clin Oncol Date: 1994-11 Impact factor: 44.544

8. Treatment of sulphasalazine-induced agranulocytosis with granulocyte macrophage-colony stimulating factor.

Authors: P Roddie; H Dorrance; M K Cook; J B Rainey
Journal: Aliment Pharmacol Ther Date: 1995-12 Impact factor: 8.171

9. Autoimmune neutropenia: clinical and laboratory studies in 143 patients.

Authors: J Bux; K Kissel; K Nowak; U Spengel; C Mueller-Eckhardt
Journal: Ann Hematol Date: 1991-11 Impact factor: 3.673

10. Drug-induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.

Authors: R Hurtado; M Candelaria; A Majluf-Cruz; R E Sosa-Camas; J Labardini-Méndez
Journal: Rev Invest Clin Date: 1994 Jan-Feb Impact factor: 1.451

19 in total

1. Antagonism between MCL-1 and PUMA governs stem/progenitor cell survival during hematopoietic recovery from stress.

Authors: Alex R D Delbridge; Joseph T Opferman; Stephanie Grabow; Andreas Strasser
Journal: Blood Date: 2015-04-06 Impact factor: 22.113

2. Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years.

Authors: Hyunkyung Park; Jeonghwan Youk; Hak Ro Kim; Youngil Koh; Ji Hyun Kwon; Sung-Soo Yoon; Seonyang Park; Pyoeng Gyun Choe; Nam Joong Kim; Myoung-Don Oh; Wan Beom Park; Inho Kim
Journal: Int J Hematol Date: 2017-08-20 Impact factor: 2.490

3. Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study.

Authors: Daniel W Gunda; Kahamba G Godfrey; Semvua B Kilonzo; Bonaventura C Mpondo
Journal: Malawi Med J Date: 2017-03 Impact factor: 0.875

Severe neutropenia: a diagnostic approach.

Review 1. Autoimmune neutropenia.

Review 2. Differential diagnoses of bone marrow granuloma.

Review 3. Immunology of sarcoidosis.

4. 1997 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

5. Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis.

6. Descriptive epidemiology of agranulocytosis.

Review 7. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.

8. Treatment of sulphasalazine-induced agranulocytosis with granulocyte macrophage-colony stimulating factor.

9. Autoimmune neutropenia: clinical and laboratory studies in 143 patients.

10. Drug-induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.

1. Antagonism between MCL-1 and PUMA governs stem/progenitor cell survival during hematopoietic recovery from stress.

2. Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years.

3. Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study.

4. Delayed, transient and self-resolving neutropenia following COVID-19 pneumonia.

5. Bottom-up modeling approach for the quantitative estimation of parameters in pathogen-host interactions.

Review 6. Blood disorders typically associated with renal transplantation.

7. Contrast medium-induced transient severe leukopenia.

8. Invasive Candidiasis Associated with Adenovirus Pneumonia.

9. Benazepril-Induced Agranulocytosis: A Case Report and Review of the Literature.

10. A case of recurrent agranulocytosis due to levamisole.